CRISPR and Genome Editing – Products

Product News
BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius
BioPharmaSpec has officially announced three new European facilities. The new facilities will focus on discovery and R&D services, offering structural and physicochemical characterization services for a wide variety of biopharmaceutical products.

Product News
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for clinical-grade drug substance manufacturing.

Product
Advertisement
ELEVECTA™ Producer Cell Line: For Stable, Inducible Adeno-Associated Virus Production
ELEVECTA™ producer cell line is a true producer cell line with all four required genes ― rep, helper, cap, and gene of interest (GOI) ― stably integrated into the host cell’s genome.

Product News
Aptamer Extends Agreement With Genetic Medicines Customer
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders, is pleased to announce that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.

Product
Advertisement
BioPhase 8800 System: Multi-Assay, Multi-Capillary Electrophoresis System
Access this collection of resources to explore how capillary electrophoresis (CE) and mass spectrometry (MS) solutions can help you ensure the quality, safety and efficacy of your new drug candidates.

Compendium
Achieving Cell and Gene Therapy Excellence
This compendium explores analytical advancements in cell and gene therapy, highlighting the latest tools and strategies for ensuring therapeutic quality.

Product News
eXmoor and Virica Receive Funding To Improve AAV Gene Therapy Manufacturing
eXmoor pharma, and Virica Biotech Inc. (“Virica”), announced a new project funded in part through a joint Canada-UK government biomanufacturing collaboration.

Product News
Cellular Origins and Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announces they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs).

Product News
Direct Translocation of Proteins Into Living Cells
BioPORTER® protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.

Product News
Bio-Rad Launches High-Precision Vericheck ddPCR Empty-Full Capsid Kit To Advance Development of Safe and Effective Gene Therapies
Vericheck ddPCR empty-full capsid kit combines measuring viral titer and capsid titer, providing a high-precision assessment for critical quality attributes of both protein and DNA in droplets.
Advertisement